These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3977650)

  • 21. The relationship between depression and the dexamethasone suppression test following alcohol withdrawal in a psychiatric population.
    Johnson B; Perry JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):343-9. PubMed ID: 3805327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
    Arana GW; Reichlin S; Workman R; Haaser R; Shader RI
    Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome.
    Klein HE; Bender W; Mayr H; Niederschweiberer A; Schmauss M
    Br J Psychiatry; 1984 Dec; 145():591-9. PubMed ID: 6509268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trazodone therapy of the post-stroke depression.
    Raffaele R; Rampello L; Vecchio I; Tornali C; Malaguarnera M
    Arch Gerontol Geriatr; 1996; 22 Suppl 1():217-20. PubMed ID: 18653034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone suppression test and MMPI scales.
    Ansseau M; von Frenckell R; Franck G; Geenen V; Legros JJ
    Neuropsychobiology; 1986; 16(2-3):68-71. PubMed ID: 3587578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of the DST for predicting response of patients with major depression to hospitalization and desipramine.
    Nelson JC; Mazure CM; Jatlow PI
    Am J Psychiatry; 1990 Nov; 147(11):1488-92. PubMed ID: 2221161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression.
    Grossman R; Yehuda R; New A; Schmeidler J; Silverman J; Mitropoulou V; Sta Maria N; Golier J; Siever L
    Am J Psychiatry; 2003 Jul; 160(7):1291-8. PubMed ID: 12832244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The DST as a predictor of outcome in depression: a meta-analysis.
    Ribeiro SC; Tandon R; Grunhaus L; Greden JF
    Am J Psychiatry; 1993 Nov; 150(11):1618-29. PubMed ID: 8214170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlations between clinico-psychiatric findings and the dexamethasone suppression test in depression].
    Rupprecht R; Barocka A; Pichl J
    Psychiatr Prax; 1988 Jul; 15(4):142-5. PubMed ID: 3406225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial dexamethasone tests for predicting relapse in depressive disorder.
    Targum SD
    South Med J; 1984 Nov; 77(11):1402-5. PubMed ID: 6494962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone suppression in depressed elderly outpatients.
    Allen RE; Pitts FN
    J Clin Psychiatry; 1984 Sep; 45(9):397-8. PubMed ID: 6469926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?
    Miller KB; Nelson JC
    Arch Gen Psychiatry; 1987 Sep; 44(9):769-74. PubMed ID: 3632250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.
    Carroll BJ; Feinberg M; Greden JF; Tarika J; Albala AA; Haskett RF; James NM; Kronfol Z; Lohr N; Steiner M; de Vigne JP; Young E
    Arch Gen Psychiatry; 1981 Jan; 38(1):15-22. PubMed ID: 7458567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J; Linka M; Matkowski K; Kanarkowski R
    Psychiatr Pol; 1991; 25(5):9-15. PubMed ID: 1821997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia.
    Raskind M; Peskind E; Rivard MF; Veith R; Barnes R
    Am J Psychiatry; 1982 Nov; 139(11):1468-71. PubMed ID: 7137397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone suppression test in depressive illness: its relation to anxiety symptoms.
    Saleem PT
    Br J Psychiatry; 1984 Feb; 144():181-4. PubMed ID: 6704604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dexamethasone suppression test in schizophrenia.
    Ismail K; Murray RM; Wheeler MJ; O'Keane V
    Psychol Med; 1998 Mar; 28(2):311-7. PubMed ID: 9572089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.